Investment Memo: FOXO
Date: 5th January, 2025
Series: Pre-Seed
About the company
- FOXO is a health tech company (pre revenue) with the aim of helping people live longer through detailed assessments, personalized coaching, food and lifestyle protocols all integrated seamlessly with technology leveraging latest advancements in systems biology and advanced diagnostics.
- The company's flagship product, a Longevity Coach, is tailored for *India's top 1%, providing personalized health insights and actionable recommendations. Over time, FOXO aims to broaden its impact by offering a scaled, lite version of the product for the premium mass market, making longevity accessible to more people.
Team
Some reasons why I am investing:
- Exciting category with traction and large TAM - With the likes of Bryan Johnson, Peter Attia, Andrew Hubberman, Luke Coutinho and wearables like Whoop, Aura ring, etc becoming more popular than ever - Health for the top 1% is an exciting category ripe for disruption.
- Experienced founders with a long term mindset - All 3 founders have built companies in the past at different scales, with different outcomes. All of them spent on average 10 years+ building their past company and have known each other for many years.
- Started from a deep personal experience - Subhendu started this company when he faced deep and severe personal health issues which he reversed after working with some of the best doctors in India over more than a year (details about personal journey shared later).
- Top tier VC investing for second time - Blume backed Skillenza and Instamojo when Subhendu and Akash were building it respectively and is backing FOXO again by leading this round, showing trust and repeat conviction in founders.